May 8, 2009 - Lannett Company, Inc., a manufacturer of generic pharmaceuticals, today announced that it has received approval from the U.S. FDA of its supplemental Abbreviated New Drug Application for Pilocarpine HCI tablets, 7.5 mg, the generic equivalent of Salagen, marketed by Eisai Pharmaceuticals.
The details can be read here.
No comments:
Post a Comment